Search This Blog

Friday, July 31, 2020

Merck EPS beats by $0.32, beats on revenue

Merck (NYSE:MRK): Q2 Non-GAAP EPS of $1.37 beats by $0.32; GAAP EPS of $1.18 beats by $0.27.
Revenue of $10.87B (-7.6% Y/Y) beats by $350M.
Keytruda revenues of $3.39B vs. consensus of $3.13B.
Januvia/Janumet sales of $1.34B vs. estimate of $1.26B.
Shares +1.41% PM.
Press Release

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)